captopril has been researched along with ascorbic acid in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.33) | 18.7374 |
| 1990's | 10 (41.67) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bhuyan, DK; Bhuyan, KC; Podos, SM; Santos, O | 1 |
| Antonaccio, MJ; Greenberg, R; O'Keefe, EH | 1 |
| Breckenridge, AM; Park, BK; Yeung, JH | 1 |
| Hipple, TF; Morosco, RS; Nahata, MC | 2 |
| Kaufman, MJ | 1 |
| Persu, A; Pirson, Y | 1 |
| Bartosz, G; Bartosz, M; Kedziora, J | 1 |
| Mittra, S; Singh, M | 1 |
| Coe, FL; Nakagawa, Y | 1 |
| Csako, G | 1 |
| Dasgupta, T; McGowder, D; Ragoobirsingh, D | 1 |
| Alken, P; Janitzky, V; Knoll, T; Köhrmann, KU; Michel, MS | 1 |
| Aquart, DV; Dasgupta, TP | 1 |
| Aso, Y; Inukai, T; Inukai, Y; Matsutomo, R; Nakamachi, T; Takahashi, K; Takanashi, K; Takebayashi, K; Wakabayashi, S; Yoshida, N | 1 |
| Hashemi, F; Rastegarzadeh, S | 1 |
| Carpenter, A; Dale-Harris, I; Dorée, C; Estcourt, LJ; Roy, NB | 1 |
4 review(s) available for captopril and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Current aspects of the medical treatment of cystinuria].
Topics: Ascorbic Acid; Captopril; Cystine; Cystinuria; Humans; Hydrogen-Ion Concentration; Penicillamine; Solubility; Tiopronin; Urine | 1994 |
[Cystinuria - Cystine Stones: Recommendations for Diagnosis, Therapy and Follow-up].
Topics: Adult; Age Factors; Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Captopril; Chelating Agents; Child; Cystinuria; Follow-Up Studies; Humans; Kidney Calculi; Lithotripsy; Penicillamine; Time Factors; Tiopronin; Ureteroscopy | 2003 |
Interventions for chronic kidney disease in people with sickle cell disease.
Topics: Acute Chest Syndrome; Adolescent; Adult; Anemia, Sickle Cell; Angiotensin-Converting Enzyme Inhibitors; Antisickling Agents; Ascorbic Acid; Captopril; Child; Creatinine; Humans; Hydroxyurea; Kidney Failure, Chronic; Lisinopril; Proteinuria | 2023 |
20 other study(ies) available for captopril and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Antioxidant and anticataractogenic effects of topical captopril in diquat-induced cataract in rabbits.
Topics: Administration, Topical; Animals; Antioxidants; Ascorbic Acid; Captopril; Cataract; Diquat; Eye; Female; Hydrogen Peroxide; Lens, Crystalline; Lipid Peroxidation; Male; Rabbits; Sulfhydryl Compounds; Superoxides | 1992 |
The effect of captopril and ascorbic acid on nonenzymatic methionine enkephalin inactivation in the guinea-pig ileum.
Topics: Animals; Ascorbic Acid; Captopril; Endorphins; Enkephalin, Leucine; Enkephalin, Methionine; Enkephalins; Guinea Pigs; Ileum; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Proline; Puromycin; Sodium Hypochlorite; Teprotide | 1981 |
Drug protein conjugates--VI. Role of glutathione in the metabolism of captopril and captopril plasma protein conjugates.
Topics: Acetaminophen; Alanine Transaminase; Animals; Ascorbic Acid; Blood Proteins; Captopril; Cysteine; Glutathione; Liver; Male; Mice; Mice, Inbred CBA; Penicillamine; Proline; Protein Binding; Rats; Rats, Inbred Strains | 1983 |
Stability of captopril in liquid containing ascorbic acid or sodium ascorbate.
Topics: Ascorbic Acid; Captopril; Drug Stability; Drug Storage; Humans; Temperature | 1994 |
Comparison of the free radical-scavenging ability of captopril and ascorbic acid in an in-vitro model of lipid oxidation. Implications for reperfusion injury and ACE inhibitor therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Ascorbic Acid; Captopril; Diffusion; Free Radical Scavengers; Linoleic Acid; Linoleic Acids; Lipid Peroxidation; Micelles; Oxidation-Reduction; Oxygen Consumption; Phospholipids; Reperfusion Injury; Sodium Dodecyl Sulfate | 1994 |
Stability of captopril in three liquid dosage forms.
Topics: Antioxidants; Ascorbic Acid; Captopril; Chromatography, High Pressure Liquid; Drug Stability; Solutions; Spectrophotometry, Ultraviolet | 1994 |
Antioxidant and prooxidant properties of captopril and enalapril.
Topics: Adenosine Triphosphatases; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Captopril; Deoxyribose; DNA Damage; Enalapril; Erythrocyte Membrane; Hemolysis; Humans; Lipid Peroxidation; Oxidation-Reduction | 1997 |
Possible mechanism of captopril induced endothelium-dependent relaxation in isolated rabbit aorta.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Ascorbic Acid; Captopril; Chlorides; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Ferric Compounds; In Vitro Techniques; Lipid Peroxidation; Male; Muscle Relaxation; Phenylephrine; Rabbits; Reactive Oxygen Species; Sulfhydryl Compounds; Superoxide Dismutase | 1998 |
A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference.
Topics: Adult; Artifacts; Ascorbic Acid; Captopril; Chlorides; Colorimetry; Creatinine; Cyanides; Cysteine; Cystinuria; Dose-Response Relationship, Drug; Female; Ferrous Compounds; Humans; Male; Middle Aged; Nitroprusside; Penicillamine; Reference Values; Reproducibility of Results; Serum Albumin; Tiopronin; Zinc Compounds | 1999 |
Mesna and other free-sulfhydryl compounds produce false-positive results in a urine test strip method for ascorbic acid.
Topics: Acetylcysteine; Ascorbic Acid; Captopril; False Positive Reactions; Humans; Mesna; Reagent Strips | 1999 |
The hyperglycemic effect of S-nitrosoglutathione in the dog.
Topics: Animals; Ascorbic Acid; Blood Glucose; Blood Pressure; Captopril; Dogs; Female; Glutathione; Heart Rate; Hemodynamics; Hyperglycemia; Insulin; Male; Nitric Oxide Donors; Nitroso Compounds; Postprandial Period; Radioimmunoassay; S-Nitrosoglutathione | 1999 |
Dynamics of interaction of vitamin C with some potent nitrovasodilators, S-nitroso-N-acetyl-d,l-penicillamine (SNAP) and S-nitrosocaptopril (SNOCap), in aqueous solution.
Topics: Ascorbic Acid; Captopril; Catalysis; Copper; Edetic Acid; Hydrogen-Ion Concentration; Kinetics; Nitric Oxide; Osmolar Concentration; Penicillamine; S-Nitrosothiols; Sodium Chloride; Solutions; Vasodilator Agents | 2004 |
Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Blood Glucose; Captopril; Diabetes Mellitus, Type 2; Female; Free Radical Scavengers; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Neutrophils; Superoxide Dismutase; Superoxides; Tetrazoles; Thiazepines | 2005 |
A surface plasmon resonance sensing method for determining captopril based on in situ formation of silver nanoparticles using ascorbic acid.
Topics: Antihypertensive Agents; Ascorbic Acid; Captopril; Limit of Detection; Metal Nanoparticles; Silver; Surface Plasmon Resonance | 2014 |